# Novelty, Conformity and Trust in COVID-19 Vaccines

> **NCT04693689** · NA · COMPLETED · sponsor: **National University of Singapore** · enrollment: 35180 (actual)

## Conditions studied

- Trust

## Interventions

- **OTHER:** RNA vaccine
- **OTHER:** 20% adoption rate
- **OTHER:** 40% adoption rate
- **OTHER:** 60% adoption rate
- **OTHER:** 80% adoption rate
- **OTHER:** Conventional vaccine
- **OTHER:** 0% adoption rate

## Key facts

- **NCT ID:** NCT04693689
- **Lead sponsor:** National University of Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-03-30
- **Target enrollment:** 35180 (ACTUAL)
- **Last updated:** 2022-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04693689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04693689, "Novelty, Conformity and Trust in COVID-19 Vaccines". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04693689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*